These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30542118)

  • 1. Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells.
    Zhang R; Hong JJ; Yang Q; Ong CT; Li BA; Liou YC
    Oncogene; 2019 Apr; 38(15):2750-2766. PubMed ID: 30542118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
    Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A
    Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly-ADP ribosylation in DNA damage response and cancer therapy.
    Hou WH; Chen SH; Yu X
    Mutat Res Rev Mutat Res; 2019; 780():82-91. PubMed ID: 31395352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function.
    Kanai M; Tong WM; Sugihara E; Wang ZQ; Fukasawa K; Miwa M
    Mol Cell Biol; 2003 Apr; 23(7):2451-62. PubMed ID: 12640128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
    Lin KY; Huang D; Kraus WL
    Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
    Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
    Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress.
    Hegedűs C; Virág L
    Redox Biol; 2014; 2():978-82. PubMed ID: 25460733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity.
    Luo X; Ryu KW; Kim DS; Nandu T; Medina CJ; Gupte R; Gibson BA; Soccio RE; Yu Y; Gupta RK; Kraus WL
    Mol Cell; 2017 Jan; 65(2):260-271. PubMed ID: 28107648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
    Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
    Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.
    Kanai M; Tong WM; Wang ZQ; Miwa M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):426-30. PubMed ID: 17553458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and Biophysical Assays of PAR-WWE Domain Interactions and Production of iso-ADPr for PAR-Binding Analysis.
    Wang Z; Xu W
    Methods Mol Biol; 2018; 1813():65-73. PubMed ID: 30097861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-wide identification of poly(ADP-Ribosyl)ation targets in different genotoxic stress responses.
    Jungmichel S; Rosenthal F; Altmeyer M; Lukas J; Hottiger MO; Nielsen ML
    Mol Cell; 2013 Oct; 52(2):272-85. PubMed ID: 24055347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of YB-1 in Regulation of Poly(ADP-Ribosylation) Catalyzed by Poly(ADP-Ribose) Polymerases.
    Alemasova EE; Naumenko KN; Sukhanova MV; Lavrik OI
    Biochemistry (Mosc); 2022 Jan; 87(Suppl 1):S32-S0. PubMed ID: 35501985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian N1-adenosine PARylation is a reversible DNA modification.
    Musheev MU; Schomacher L; Basu A; Han D; Krebs L; Scholz C; Niehrs C
    Nat Commun; 2022 Oct; 13(1):6138. PubMed ID: 36253381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose) signaling in cell death.
    Virág L; Robaszkiewicz A; Rodriguez-Vargas JM; Oliver FJ
    Mol Aspects Med; 2013 Dec; 34(6):1153-67. PubMed ID: 23416893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribosyl)ation of TIMELESS limits DNA replication stress and promotes stalled fork protection.
    Rageul J; Lo N; Phi AL; Patel JA; Park JJ; Kim H
    Cell Rep; 2024 Mar; 43(3):113845. PubMed ID: 38393943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribosyl)ation is recognized by ECT2 during mitosis.
    Li M; Bian C; Yu X
    Cell Cycle; 2014; 13(18):2944-51. PubMed ID: 25486481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.